X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (218) 218
index medicus (148) 148
infectious diseases (148) 148
female (135) 135
male (135) 135
adult (122) 122
middle aged (120) 120
microbiology (85) 85
aged (78) 78
hiv (68) 68
immunology (68) 68
hiv infections - drug therapy (56) 56
risk factors (45) 45
pharmacology & pharmacy (44) 44
medicine, general & internal (42) 42
health aspects (41) 41
virology (39) 39
cohort studies (37) 37
treatment outcome (37) 37
mortality (34) 34
antiretroviral therapy (33) 33
hiv infections - complications (31) 31
therapy (30) 30
viral load (30) 30
infection (29) 29
adolescent (28) 28
infections (28) 28
prospective studies (27) 27
retrospective studies (27) 27
aged, 80 and over (26) 26
human immunodeficiency virus--hiv (26) 26
anti-hiv agents - therapeutic use (25) 25
hiv infection (25) 25
management (25) 25
aids (24) 24
drug therapy (24) 24
hiv infections - virology (24) 24
netherlands (24) 24
prevalence (24) 24
care and treatment (23) 23
cd4 lymphocyte count (23) 23
research (23) 23
young adult (23) 23
diagnosis (22) 22
research article (22) 22
anti-bacterial agents - therapeutic use (21) 21
human-immunodeficiency-virus (21) 21
pneumonia (21) 21
time factors (21) 21
animals (20) 20
disease (20) 20
hepatitis c (20) 20
internal medicine (20) 20
antiviral agents (19) 19
patients (19) 19
netherlands - epidemiology (18) 18
adults (17) 17
antibiotics (17) 17
human immunodeficiency virus (17) 17
analysis (16) 16
antiviral agents - therapeutic use (16) 16
drug therapy, combination (16) 16
follow-up studies (16) 16
guidelines (16) 16
infectious disease (16) 16
medicine (16) 16
risk-factors (16) 16
women (16) 16
active antiretroviral therapy (15) 15
epidemiology (15) 15
hiv patients (15) 15
hiv-1 - drug effects (15) 15
aids/hiv (14) 14
anti-hiv agents - adverse effects (14) 14
antiretroviral drugs (14) 14
child (14) 14
highly active antiretroviral therapy (14) 14
hiv infections - epidemiology (14) 14
hiv infections - immunology (14) 14
diabetes (13) 13
diabetes mellitus (13) 13
hepatitis c virus (13) 13
incidence (13) 13
individuals (13) 13
viruses (13) 13
anti-hiv agents - administration & dosage (12) 12
antiretroviral therapy, highly active (12) 12
asymptomatic bacteriuria (12) 12
biomedicine (12) 12
cardiovascular disease (12) 12
cohort (12) 12
prevention (12) 12
risk (12) 12
treatment failure (12) 12
tumor-necrosis-factor (12) 12
usage (12) 12
community-acquired infections - drug therapy (11) 11
complications and side effects (11) 11
hepatitis (11) 11
infected patients (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BRITISH MEDICAL JOURNAL, ISSN 0959-8146, 01/2012, Volume 344
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2016, Volume 374, Issue 7, pp. 636 - 646
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 129, Issue 3, pp. 787 - 793.e6
Background CD27 is a lymphocyte costimulatory molecule that regulates T-cell, natural killer (NK) cell, B-cell, and plasma cell function, survival, and... 
Allergy and Immunology | phenotype | B cell | T cell | EBV | CD27 | immunodeficiency | hypogammaglobulinemia | natural killer cell | viremia | CD70 | T-CELL | IMMUNOLOGY | HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS | B-CELLS | MEMORY | ALLERGY | XIAP DEFICIENCY | GENERATION | DIFFERENTIATION | EXPRESSION | EPSTEIN-BARR-VIRUS | Gram-Positive Bacterial Infections - immunology | Anemia, Aplastic - virology | Humans | Male | Gram-Positive Bacterial Infections - virology | Severe Combined Immunodeficiency - physiopathology | Young Adult | Severe Combined Immunodeficiency - virology | T-Lymphocytes - metabolism | Fatal Outcome | Epstein-Barr Virus Infections - genetics | Gram-Positive Bacterial Infections - genetics | Herpesvirus 4, Human - pathogenicity | B-Lymphocytes - pathology | T-Lymphocytes - pathology | Gram-Positive Bacterial Infections - complications | Anemia, Aplastic - complications | Anemia, Aplastic - genetics | B-Lymphocytes - metabolism | Siblings | Epstein-Barr Virus Infections - physiopathology | Gram-Positive Bacterial Infections - physiopathology | Epstein-Barr Virus Infections - virology | Epstein-Barr Virus Infections - immunology | Immunity, Humoral - genetics | Cells, Cultured | Herpesvirus 4, Human - immunology | Viremia - genetics | Severe Combined Immunodeficiency - immunology | Tumor Necrosis Factor Receptor Superfamily, Member 7 - genetics | Mutation - genetics | Agammaglobulinemia - etiology | Anemia, Aplastic - physiopathology | Severe Combined Immunodeficiency - complications | Severe Combined Immunodeficiency - genetics | B-Lymphocytes - immunology | Viremia - virology | Pedigree | Epstein-Barr Virus Infections - complications | T-Lymphocytes - immunology | Viremia - immunology | Consanguinity | Anemia, Aplastic - immunology | Antigens | Genes | Staphylococcus aureus infections | T cells | Diseases | Virus diseases | Lymphocytes | Virus diseases in children | Medical genetics | Cross infection | Children | Tetanus | Nosocomial infections | Mitogens | Ligands | Infections | T cell receptors | Family medical history | Patients | Age | Viral infections | Fever | Immune system | CD27 antigen | Immunoglobulins | Cell survival | Viremia | Aplastic anemia | Immunodeficiency | Hypogammaglobulinemia | Lymphocytes T | Costimulator | Infection | Lymphocytes B | Plasma cells | Sepsis | Mutation | Natural killer cells | Differentiation | NK cell
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2017, Volume 65, Issue 11, pp. 1958 - 1959
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1442 - 1455
In key subgroups of the HIV-infected patients in the MOTIVATE 1 and MOTIVATE 2 studies, a consistent treatment benefit of maraviroc over placebo was seen at 48... 
CCR5 ANTAGONIST | MEDICINE, GENERAL & INTERNAL | EFFICACY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | ACTIVE ANTIRETROVIRAL THERAPY | DRUG-RESISTANT HIV-1 | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | HEPATITIS-C | PROGNOSTIC VALUE | Triazoles - adverse effects | Humans | Middle Aged | Receptors, CCR5 - genetics | Male | RNA, Viral - blood | Hepatitis B - blood | Viral Load | Hepatitis B - complications | Cyclohexanes - therapeutic use | HIV Infections - immunology | Ethnic Groups | HIV Envelope Protein gp41 - therapeutic use | HIV-1 - chemistry | Hepatitis C - blood | Adult | Female | Hepatitis C - complications | Cyclohexanes - adverse effects | Drug Therapy, Combination | Odds Ratio | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Anti-Retroviral Agents - therapeutic use | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Genotype | Treatment Outcome | CD4 Lymphocyte Count | HIV Fusion Inhibitors - adverse effects | HIV-1 - genetics | HIV Fusion Inhibitors - therapeutic use | HIV Infections - drug therapy | Transaminases - blood | Aged | Peptide Fragments - therapeutic use | Antiviral agents | Care and treatment | Maraviroc | Comparative analysis | Health aspects | HIV infection | Drug therapy | Drug resistance | Human immunodeficiency virus--HIV | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article